Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Fox

Showing results (81-90 of 119) with videos related to

Pageof 12
Sort By:
Molecular Cancer Research : MCR|December 31, 2020
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer GrowthXi Liu, Yun Lu, Zibo Chen, et al.
Scientific Reports|June 25, 2020
Publisher Correction: CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Clinical & Translational Immunology|September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survivalRosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Scientific Reports|April 25, 2019
CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized TrialJonathan G Hiller, Steven W Cole, Elizabeth M Crone, et al.
Oncotarget|February 23, 2018
Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samplesRoss A Soo, Joey Sze Yun Lim, Bernadette Reyna Asuncion, et al.
The Journal of Molecular Diagnostics : JMD|October 10, 2009
A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical settingVicki Whitehall, Kayla Tran, Aarti Umapathy, et al.
JAMA Dermatology|June 2, 2021
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz NeviSusan J Robertson, Lisa Orme, Rodrigo Teixeira, et al.
Ebiomedicine|October 11, 2020
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceYue Zhao, Ziwei Pan, Sandeep Namburi, et al.
Pageof 12

Showing results (81-90 of 119) with videos related to

Sort By:
Pageof 12
Molecular Cancer Research : MCR|December 31, 2020
The Ubiquitin-Specific Peptidase USP18 Promotes Lipolysis, Fatty Acid Oxidation, and Lung Cancer GrowthXi Liu, Yun Lu, Zibo Chen, et al.
Scientific Reports|June 25, 2020
Publisher Correction: CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Clinical & Translational Immunology|September 21, 2020
CD8<sup>+</sup> tumor-infiltrating lymphocytes within the primary tumor of patients with synchronous <i>de novo</i> metastatic colorectal carcinoma do not track with survivalRosemary Millen, Shona Hendry, Vignesh Narasimhan, et al.
Scientific Reports|April 25, 2019
CNspector: a web-based tool for visualisation and clinical diagnosis of copy number variation from next generation sequencingJohn F Markham, Satwica Yerneni, Georgina L Ryland, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 23, 2019
Preoperative β-Blockade with Propranolol Reduces Biomarkers of Metastasis in Breast Cancer: A Phase II Randomized TrialJonathan G Hiller, Steven W Cole, Elizabeth M Crone, et al.
Oncotarget|February 23, 2018
Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samplesRoss A Soo, Joey Sze Yun Lim, Bernadette Reyna Asuncion, et al.
The Journal of Molecular Diagnostics : JMD|October 10, 2009
A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical settingVicki Whitehall, Kayla Tran, Aarti Umapathy, et al.
JAMA Dermatology|June 2, 2021
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz NeviSusan J Robertson, Lisa Orme, Rodrigo Teixeira, et al.
Ebiomedicine|October 11, 2020
CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceYue Zhao, Ziwei Pan, Sandeep Namburi, et al.
Pageof 12